EJC Paediatric Oncology Pediatrics

A Randomized, open-label, phase 2 study evaluating abemaciclib in combination with irinotecan and temozolomide in patients with relapsed or refractory Ewing sarcoma

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →